WIRE)–Hitachis 64-slice SCENARIA is now in worldwide clinical use, where it is
proving itself as an excellent lower dose* and optimum value clinical platform
for both routine and advanced applications.
“SCENARIA goes beyond being just another versatile 64-slice
CT, by including unique dose reduction features for its segment, such as
combining a lateral-shifting table-top with a smaller x-ray bow-tie filter, to
provide both improved resolution and reduced dose,” said Mark Silverman,
Manager of CT Marketing. “And, SCENARIA offers a breadth of other important
features, including Intelli EC -Exposure Control and Intelli IP -Iterative
Processing for dose reduction, together an enlarged 75cm gantry aperture, for
greater access and comfort.”
Considering that published clinical studies demonstrate
64-slice CT has a 99% negative predictive value in excluding Major Cardiac
Adverse Events (MACE) for 30 days in patients who present with acute coronary
syndrome (ACS), 64-slice CT fulfills most providers CT needs for lower
dose with routine and advanced cardiac applications, without the added
financial burden of purchasing a dramatically higher cost, higher slice CT
SCENARIA also excels in 3D visualization and analysis
capabilities critical to physicians, by offering an integrated TeraRecon
iNtuition® server with a full range of advanced clinical applications that are
simultaneously available to multiple users.
About Hitachi Medical Systems America, Inc.
Hitachi Medical Systems America (HMSA) located in
Twinsburg, Ohio, a wholly owned subsidiary of Hitachi Medical Corporation
offers a broad range of diagnostic imaging equipment including MRI, CT and
Ultrasound. Our innovations in diagnostic imaging provide technology that
drives clinical solutions to deliver diagnostic confidence, improve workflow
efficiency and provide a better patient experience. In addition to exceptional
equipment, HMSA is known for its comprehensive customer support programs to
maximize the lifecycle value of equipment through responsive service
maintenance, significant software upgrades and on-going applications support.
About Hitachi, Ltd.
Hitachi, Ltd., (NYSE: HIT)(TOKYO:
6501), headquartered in Tokyo,
Japan, is a
leading global electronics company with approximately 362,000 employees worldwide
on the consolidated basis. Fiscal 2010 (ended March 31, 2011) consolidated
revenues totaled 9,316 billion yen ($110.9 billion). Hitachi will focus more than ever on the
Social Innovation Business, which includes Information and Telecommunication
Systems, Power Systems, Industrial, Transportation and Urban Development
Systems, as well as the sophisticated Materials and Key Devices that support
*In clinical use, dose saving features may reduce CT patient
dose depending on the clinical task, patient size, anatomical location and
clinical practices employed. Consultation with a radiologist and physicist are
recommended to determine the appropriate dose needed to obtain diagnostic image
quality for a particular clinical task.